Congratulations to H2i venture Synakis who won first place at TERMIS-AM‘s Business Plan Competition! The competition, which took place during TERMIS-AM’s annual conference in Boston, featured five selected finalists—all healthcare entrepreneurs working to use tissue engineering strategies to enhance human health and longevity. 

Synakis, a venture from University of Toronto’s Shoichet Lab, is looking to innovate the use of ocular biomaterial solutions to improve the treatment of retinal detachment and other forms of retinal damage. Current intervention processes are burdensome and can result in extensive head posturing, need for subsequent surgery, blurred vision and time away from work and leisure activities. The Synakis team have developed a solution to these challenges in the form of a novel hydrogel which is non-swelling, transparent, bioresorbable and identical to the body’s naturally produced substance. 

The innovative work was presented at the competition by Synakis Co-Founder Mickael Dang, a PhD student in Chemical Engineering at University of Toronto. Judges and audience members were impressed with the team’s work to date, ultimately awarding them top prize. 

“Pitching at the business plan competition from the TERMIS-AM 2023 annual meeting in Boston was an amazing experience! It validated our hard work and dedication to our startup Synakis, and gave us a platform to showcase our groundbreaking technology to a wider audience. The feedback and support we received from judges and attendees was invaluable, and we left the competition feeling inspired and motivated to continue pursuing our goals.” 
-Mickael Dang, MASc, EMSc 
Business Development & Marketing, Synakis 

Congratulations to the Synakis team for this impressive accomplishment! The H2i team looks forward to seeing Synakis continue to grow. 

Synakis will be competing in Medicine by Design’s Building a Biotech Venture Pitch Competition on May 2nd, 2023! To find out more and register to watch this event live, click here!